Serine starvation in p53-deficient tumor cells induces oxidative stress and reduces cell viability in vitro and in vivo, highlighting the potential role of targeting serine dependency in the treatment of tumors with p53 deficiency (96). This evidence concerns the gene TP53 and neoplasm.